PepsiCo Chief Monetary Officer Hugh Johnston says the meals and snack maker shouldn’t be seeing the affect of Ozempic or different appetite-suppressing medicine on its gross sales. Johnston says the corporate is watching the pattern, however he would not assume snacking is not going away. He speaks on “Bloomberg Markets.”
Observe Bloomberg for enterprise information & evaluation, up-to-the-minute market knowledge, options, profiles and extra: http://www.bloomberg.com
Join with us on…
Twitter: https://twitter.com/enterprise
Fb: https://www.fb.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en
